Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis Shi-Yi WangTatyana ShamliyanRobert Kane Review 15 February 2011 Pages: 1 - 14
Radiotherapy and breast reconstruction: a meta-analysis M BarryM. R. Kell Review 20 February 2011 Pages: 15 - 22
Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies Jia-Yi DongLijun ZhangLi-Qiang Qin Review 27 March 2011 Pages: 23 - 31
Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 Bianca MostertJaco KraanStefan Sleijfer Preclinical study 09 April 2010 Pages: 33 - 41
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer F. Germán Rodríguez-GonzálezAnieta M. SieuwertsJohn A. Foekens Preclinical study 19 May 2010 Pages: 43 - 51
DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer Devon R. GermainKathryn GrahamRoseline Godbout Preclinical study 25 May 2010 Pages: 53 - 63
Dead-box or black-box: is DDX1 a potential biomarker in breast cancer? Justin M. BalkoCarlos L. Arteaga Invited Commentary 08 August 2010 Pages: 65 - 67
Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer Yingchun ZhaoCaishu DengGary Guishan Xiao Preclinical study 10 June 2010 Pages: 69 - 80
Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers Haseeb Ilias BashaVenkataswarup TiriveedhiT. Mohanakumar Preclinical study 11 June 2010 Pages: 81 - 89
RETRACTED ARTICLE: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin Steven M. HillChi ChengDavid E. Blask Preclinical study 12 June 2010 Pages: 91 - 98
An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer Sahar M. A. MahmoudEmma C. PaishAndrew R. Green Preclinical study 17 June 2010 Pages: 99 - 108
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition Annette HaydenPeter W. M. JohnsonSimon J. Crabb Preclinical study 17 June 2010 Pages: 109 - 119
Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study F. FitzalO. RiedlM. Gnant Clinical trial 17 September 2010 Pages: 121 - 128
Neoadjuvant chemotherapy for breast cancer: a surgeon’s checklist Tara M. Breslin Invited Commentary 04 February 2011 Pages: 129 - 131
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20 Gong TangSteven ShakNorman Wolmark Clinical trial 11 January 2011 Pages: 133 - 142
Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1–4 years: N-SAS BC 03 Shozo OhsumiKojiro ShimozumaTomohiko Aihara Clinical trial 24 February 2011 Pages: 143 - 152
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer Roisin M. ConnollyMichelle A. RudekAntonio C. Wolff Clinical trial 25 February 2011 Pages: 153 - 162
Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients Merlijn HuttemanJ. Sven D. MieogAlexander L. Vahrmeijer Clinical trial 01 March 2011 Pages: 163 - 170
The effect of various vitamin D supplementation regimens in breast cancer patients Luke J. PepponeAlissa J. HustonGary R. Morrow Clinical trial 08 March 2011 Pages: 171 - 177
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study George PentheroudakisAnna BatistatouGeorge Fountzilas Clinical trial 09 March 2011 Pages: 179 - 193
Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study Adriana J. Maaskant-BraatLonneke V. van de Poll-FranseGrard A. Nieuwenhuijzen Epidemiology 03 August 2010 Pages: 195 - 203
Prognostic significance of micrometastasis and isolated tumor cells in the sentinel lymph node Junko Ozao-ChoyArmando E. Giuliano Invited Commentary 03 November 2010 Pages: 205 - 206
Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years Maurice J. C. van der SangenFenneke M. M. van de WielAdri C. Voogd Epidemiology 12 August 2010 Pages: 207 - 215
Should breast conservation be offered to young women with breast cancer? Wendy A. WoodwardThomas A. Buchholz Invited Commentary 14 October 2010 Pages: 217 - 219
Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases Arnaud SeigneurinC. ExbrayatM. Colonna Epidemiology 31 August 2010 Pages: 221 - 228
False positive mammograms in Europe: do they affect reattendance? Talya SalzJessica T. DeFrankNoel T. Brewer Invited Commentary 04 November 2010 Pages: 229 - 231
Risk of second breast cancer according to estrogen receptor status and family history Christine BouchardySimone BenhamouElisabetta Rapiti Epidemiology 29 September 2010 Pages: 233 - 241
The non-breast-cancer death rate among breast cancer patients Devon BushBarbara SmithJames S. Michaelson Epidemiology 07 October 2010 Pages: 243 - 249
Ductal carcinoma in situ: trends in treatment over time in the US Jo Anne ZujewskiLinda C. HarlanJennifer L. Stevens Epidemiology 08 October 2010 Pages: 251 - 257
No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk Thomas DünnebierKlaus SchlaeferUte Hamann Epidemiology 09 October 2010 Pages: 259 - 264
LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province Zhenkun FuMingli JiaoDianjun Li Epidemiology 17 October 2010 Pages: 265 - 271
Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis Anthony GonçalvesPascal FinettiFrançois Bertucci Brief Report 11 November 2010 Pages: 273 - 281
Biomarkers of PARP inhibitor sensitivity Nicholas C. TurnerAlan Ashworth Invited Commentary 08 February 2011 Pages: 283 - 286
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers Kelly MetcalfeHenry T. LynchSteven A. Narod Brief Report 09 January 2011 Pages: 287 - 296
Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women Lenora W. M. LooYinghui WangPeggy L. Porter Brief Report 25 January 2011 Pages: 297 - 308
